[REGN] YoY Quarter Result on 31-Mar-2005 [#Q1]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
09-May-2005
Financial Year
2005
Quarter
31-Mar-2005 [#Q1]
Profit Trend
QoQ- -247.67%
YoY-
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
Revenue 112,204 103,534 74,981 56,383 15,788 18,219 16,209 38.03%
PBT -43,663 -30,304 -17,481 -8,607 -26,906 0 -1,110 84.36%
Tax -216 218 -3,500 -11,597 -10,475 -1,283 -51,447 -59.81%
NP -43,447 -30,522 -17,481 -11,618 -29,917 -20,380 -4,123 48.04%
Tax Rate - - - - - - - -
Total Cost 155,651 134,056 92,462 68,001 45,705 38,599 20,332 40.36%
Ratio Analysis
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
NP Margin -38.72 -29.48 -23.31 -20.61 -189.49 -111.86 -25.44 7.24%
Per Share
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
EPS -0.49 -0.38 -0.22 -0.15 -0.46 -0.36 -0.07 38.28%
EPS Diluted -0.49 -0.38 -0.22 -0.15 -0.46 -0.36 -0.07 38.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.